Author

Aditi Pedgaonkar

Institutions: Sanford Burnham Prebys Medical Discovery Institute, National Cancer Institute

Observed institutions: Sanford Burnham Prebys Medical Discovery Institute, Tata Memorial Hospital, National Cancer Institute, Advanced Centre for Treatment, Research and Education in Cancer

OpenAlex ID: A5043461280

Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines

2023 · Abhiram Natu, Aditi Pedgaonkar, et al. · Biochemical and Biophysical Research Communications · 15

Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesis

2025 · Rema Iyer, Anagha Deshpande, et al. · The EMBO Journal · 5

Targeting Tudor domains in leukemia: epigenetic insights for drug development

2025 · Aditi Pedgaonkar, Neha Niranjan, et al. · Epigenomics · 2

Works count: 3

Citation count: 22

H-index: 2

I10-index: 1